Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes

Deborah E. Sellmeyer; Roberto Civitelli; Lorenz C. Hofbauer; Sundeep Khosla; Beata Lecka-Czernik; Ann V. Schwartz

doi:10.2337/db16-0063

Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes

Deborah E. Sellmeyer, Roberto Civitelli, Lorenz C. Hofbauer, Sundeep Khosla, Beata Lecka-Czernik, Ann V. Schwartz

Research output: Contribution to journal › Review article › peer-review

144 Scopus citations

Abstract

Fracture risk is significantly increased in both type 1 and type 2 diabetes, and individuals with diabetes experience worse fracture outcomes than normoglycemic individuals. Factors that increase fracture risk include lower bone mass in type 1 diabetes and compromised skeletal quality and strength despite preserved bone density in type 2 diabetes, as well as the effects of comorbidities such as diabetic macro- and microvascular complications. In this Perspective, we assess the developing scientific knowledge regarding the epidemiology and pathophysiology of skeletal fragility in patients with diabetes and the emerging data on the prediction, treatment, and outcomes of fractures in individuals with type 1 and type 2 diabetes.

Original language	English
Pages (from-to)	1757-1766
Number of pages	10
Journal	Diabetes
Volume	65
Issue number	7
DOIs	https://doi.org/10.2337/db16-0063
State	Published - Jul 1 2016

Access to Document

10.2337/db16-0063

Cite this

@article{05b1c9738c8b451a96000e258b2b24d9,

title = "Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes",

abstract = "Fracture risk is significantly increased in both type 1 and type 2 diabetes, and individuals with diabetes experience worse fracture outcomes than normoglycemic individuals. Factors that increase fracture risk include lower bone mass in type 1 diabetes and compromised skeletal quality and strength despite preserved bone density in type 2 diabetes, as well as the effects of comorbidities such as diabetic macro- and microvascular complications. In this Perspective, we assess the developing scientific knowledge regarding the epidemiology and pathophysiology of skeletal fragility in patients with diabetes and the emerging data on the prediction, treatment, and outcomes of fractures in individuals with type 1 and type 2 diabetes.",

author = "Sellmeyer, {Deborah E.} and Roberto Civitelli and Hofbauer, {Lorenz C.} and Sundeep Khosla and Beata Lecka-Czernik and Schwartz, {Ann V.}",

note = "Publisher Copyright: {\textcopyright} 2016 by the American Diabetes Association.",

year = "2016",

month = jul,

day = "1",

doi = "10.2337/db16-0063",

language = "English",

volume = "65",

pages = "1757--1766",

journal = "Diabetes",

issn = "0012-1797",

number = "7",

}

TY - JOUR

T1 - Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes

AU - Sellmeyer, Deborah E.

AU - Civitelli, Roberto

AU - Hofbauer, Lorenz C.

AU - Khosla, Sundeep

AU - Lecka-Czernik, Beata

AU - Schwartz, Ann V.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Fracture risk is significantly increased in both type 1 and type 2 diabetes, and individuals with diabetes experience worse fracture outcomes than normoglycemic individuals. Factors that increase fracture risk include lower bone mass in type 1 diabetes and compromised skeletal quality and strength despite preserved bone density in type 2 diabetes, as well as the effects of comorbidities such as diabetic macro- and microvascular complications. In this Perspective, we assess the developing scientific knowledge regarding the epidemiology and pathophysiology of skeletal fragility in patients with diabetes and the emerging data on the prediction, treatment, and outcomes of fractures in individuals with type 1 and type 2 diabetes.

AB - Fracture risk is significantly increased in both type 1 and type 2 diabetes, and individuals with diabetes experience worse fracture outcomes than normoglycemic individuals. Factors that increase fracture risk include lower bone mass in type 1 diabetes and compromised skeletal quality and strength despite preserved bone density in type 2 diabetes, as well as the effects of comorbidities such as diabetic macro- and microvascular complications. In this Perspective, we assess the developing scientific knowledge regarding the epidemiology and pathophysiology of skeletal fragility in patients with diabetes and the emerging data on the prediction, treatment, and outcomes of fractures in individuals with type 1 and type 2 diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84975887035&partnerID=8YFLogxK

U2 - 10.2337/db16-0063

DO - 10.2337/db16-0063

M3 - Review article

C2 - 27329951

AN - SCOPUS:84975887035

SN - 0012-1797

VL - 65

SP - 1757

EP - 1766

JO - Diabetes

JF - Diabetes

IS - 7

ER -

Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes

Abstract

Access to Document

Other files and links

Fingerprint

Cite this